Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jun 14, 2018; 24(22): 2400-2405
Published online Jun 14, 2018. doi: 10.3748/wjg.v24.i22.2400
Figure 2
Figure 2 Kaplan-Meier analyses of disease-specific survival N stage III pancreatic cancer patients. There was no significant difference between the T(1-3)N2 and T4N(0-1) groups (P = 0.124). However, compared with stage T4N2, the DSS curve of T(1-3)N2/T4N(0-1) was significantly better [stage T(1-3)N2 vs T4N2: P = 0.014; stage T4N(0-1) vs T4N2: P = 0.003; stage T(1-3)N2 + T4N(0-1) vs T4N2: P = 0.011]. DSS: Disease-specific survival.